MP

Madhavi Peddi

Active Director Director DIN 09602879
DIN 09602879 First appointment May 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Madhavi Peddi

Data last updated:

Madhavi Peddi is a Director at Winkem Labs Private Limited (since 2022). The company operates in Healthcare. Winkem Labs Private Limited reported revenue of ₹3.57 Cr (FY 2025).

DIN 09602879
Primary Designation Director
Industry Healthcare
First Appointment 11 May 2022
Oldest Company Age 4 yrs
Largest company Winkem Labs Private Limited · ₹3.57 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Winkem Labs Private Limited U73100TG2022PTC162537
Director11 May 20222022₹3.57 Cr (FY 2025)Active

Board colleagues of Madhavi Peddi

Directorship timeline

Open interactive timeline →
Winkem Labs Private Limited
Premium access

Shareholding and investment profile for Madhavi Peddi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madhavi Peddi

Madhavi Peddi currently holds 1 directorship: Winkem Labs Private Limited (Director, since 11 May 2022, revenue ₹3.57 Cr (FY 2025)).

Madhavi Peddi was first appointed on 11 May 2022 as Director at Winkem Labs Private Limited.

The current boards of Madhavi Peddi's companies include Pavani Yadlapalli (Winkem Labs Private Limited), Srinivasa Rao Peddi (Winkem Labs Private Limited), Trilochan Padhi (Winkem Labs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available